GATA1 Expression in BCR/ABL1-negative Myeloproliferative Neoplasms

BACKGROUND: This study aimed to determine GATA1 expression levels to better characterize subgroups in BCR/ABL1-negative myeloproliferative neoplasms (MPNs). METHODS: This study enrolled 49 patients diagnosed as having BCR/ABL1-negative MPN on the basis of the 2016 World Health Organization classific...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Naery, Park, Sholhui, Cho, Min-Sun, Lee, Miae, Hong, Ki-Sook, Mun, Yeung Chul, Seong, Chu-Myong, Huh, Hee Jin, Huh, Jungwon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Laboratory Medicine 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895858/
https://www.ncbi.nlm.nih.gov/pubmed/29611379
http://dx.doi.org/10.3343/alm.2018.38.4.296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895858/
https://www.ncbi.nlm.nih.gov/pubmed/29611379
http://dx.doi.org/10.3343/alm.2018.38.4.296

Ejemplares similares